Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

GH Guardant Health, Inc. Common Stock
$179.38 -2.03% -3.72
Notify me if price changes either direction
Interactive Brokers Logotype

Buy GH stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 24.1B
Enterprise value 24.7B
Trailing PE -54.054218889719
Forward PE -450.66956
PEG Ratio -4.3243375111775
Enterprise to EBITDA -57.402
Enterprise to revenue 20.89
Price to book MRQ -106.98897868258
Price to sales TTM 20.346554

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 1.2B
EBITDA -430571008
Diluted EPS TTM -3.52
Total Cash (MRQ) 1.1B
Current ratio (MRQ) 4.026
Operating Cash Flow (TTM) -185187008

GH trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.